Projects per year
Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2024.08- Associate Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11-2024.07 Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the Radiotherapeutic Potentiation of Nanoformulated Zerumbone in Proton Therapy for Head and Neck Cancer: Mechanistic Insights, Formulation Development, and Translational Perspectives
Lee, H.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
應用深度學習與放射組學技術，精確預測立體定向放射外科手術後的局部腦部復發
Lee, H.-L. (PI)
1/1/25 → 12/31/25
Project: B - Project of TMU › i - Other (Funded by TMU)
-
The Development of Combined Hyperthermia and Proton Therapy to Overcome the Metabolic Compensation in Radioresistant Head and Neck Squamous Cell Carcinoma
Lee, H.-L. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
針對缺氧相關因子與緩激肽B1 受體-水通道蛋白4 訊號軸以克服多形性膠質母細胞瘤放射拮抗性之研究
Lee, H.-L. (PI)
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
新聘教師研究補助
Lee, H.-L. (PI)
5/1/21 → 4/30/22
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation
Wu, M. S., Kao, W. Y., Chiang, M. F., Chuang, P. H., Hsu, S. J., Wang, S. Y., Chang, C. W., Lin, C. C., Hung, C. H., Wu, C. H., Chen, S. C., Lee, H. L., Hwang, J. I., Liang, P. C., Lin, S. M. & Wang, C. C., 2025, (Accepted/In press) In: Liver Cancer.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Correction: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma (Biomedicines, (2023), 11, 7, (2081), 10.3390/biomedicines11072081)
Lee, H. L., Tsai, Y. C., Pikatan, N. W., Yeh, C. T., Yadav, V. K., Chen, M. Y. & Tsai, J. T., Sept 2025, In: Biomedicines. 13, 9, 2271.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis
Peng, H. Y., Chang, K. Y., Chang, W. M., Wu, C. Y., Lee, H. L., Chang, Y. C., Liu, K. J., Shiah, S. G., Kuo, C. C. & Chang, J. Y., Aug 2025, In: Neoplasia (United States). 66, 101193.Research output: Contribution to journal › Article › peer-review
Open Access -
Health risk assessment for severe COVID-19 in Taiwan: a multi-centre electronic health record study
Chang, Y. H., Burton, W., Nguyen, P. A., Khang, D. D., Chen, C. I., Huang, C. C., Lam, C. S. K., Lin, W. K., Wang, F. D., Phuc, P. T., Lu, C. Y., Lee, H. L., Hsu, M. H., Huang, C. W., Yang, H. C., Lin, S. M., Yang, C. & Hsu, J. C., 2025, In: Journal of Global Health. 15, 04236.Research output: Contribution to journal › Article › peer-review
Open Access -
Neurofibromatosis Type 1: A General Review
Liao, M., Lee, H. L., Liu, Y. L. & Wong, T. T., Nov 2025, In: Journal of Korean Neurosurgical Society. 68, 6, p. 644-651 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J.-M. (Contributor), Yan, J.-L. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Lai, I.-C. (Contributor), Yao, C.-J. (Contributor), Lai, G.-M. (Contributor), Bai, K.-J. (Contributor), Chuang, S.-E. (Contributor) & Li, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G.-M. (Contributor), Li, C.-H. (Contributor), Yeh, C.-F. (Creator), Whang-Peng, J. (Creator), Lee, H.-L. (Contributor), Yao, C.-J. (Contributor), Lai, I.-C. (Contributor), Chuang, S.-E. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor) & Yan, J.-L. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
Dataset
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Wen, Y.-C. (Creator), Lee, L.-M. (Creator), Lin, Y.-W. (Creator), Syu, S.-H. (Creator), Lin, K.-H. (Creator), Fan, Y.-C. (Creator), Lee, H.-L. (Creator), Lai, B. C. H. (Creator) & Shih, H.-J. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17009635.v1, https://tandf.figshare.com/articles/journal_contribution/Loco-regional_deep_hyperthermia_combined_with_intravesical_Mitomycin_instillation_reduces_the_recurrence_of_non-muscle_invasive_papillary_bladder_cancer/17009635/1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S.-E. (Contributor), Lai, I.-C. (Contributor), Yeh, C.-F. (Creator), Yan, J.-L. (Contributor), Yao, C.-J. (Contributor), Whang-Peng, J. (Creator), Li, C.-H. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor), Lee, H.-L. (Contributor) & Lai, G.-M. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
Dataset